Overcoming immune suppression with epigenetic modification in ovarian cancer-Reference-Cited by-同舟云学术

Overcoming immune suppression with epigenetic modification in ovarian cancer

Published:2019-02 Issue: Volume:204 Page:31-38
ISSN:1931-5244
Container-title:Translational Research
language:en
Short-container-title:Translational Research

Author:

McCaw Tyler R.,Randall Troy D.,Arend Rebecca C.

Funder

UAB

NIH

Publisher

Elsevier BV

Subject

Biochemistry (medical),Public Health, Environmental and Occupational Health,General Medicine,Physiology (medical)

Reference61 articles.

1. Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival;Karbach;Int J Cancer,2010

2. Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients;Odunsi;Pro Natl Acad Sci USA,2012

3. Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients;Sabbatini;Clin Cancer Res,2012

4. Immune checkpoint blockade: a common denominator approach to cancer therapy;Topalian;Cancer Cell,2015

5. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift;Reade;JObstet Gynaecol Can,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic modification in radiotherapy and immunotherapy for cancers;Tzu Chi Medical Journal;2024-09-05

2. A Pilot Study to Develop Paraneoplastic Cerebellar Degeneration Mouse Model;The Cerebellum;2023-02-02

3. Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers;Diseases;2022-08-08

4. Tackling drug resistance in ovarian cancer with epigenetic targeted drugs;European Journal of Pharmacology;2022-07

5. The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer;Frontiers in Endocrinology;2022-05-10